PULSED AF Post-Approval Study

NCT06578104 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 580

Last updated 2026-03-27

No results posted yet for this study

Summary

PULSED AF PAS is a prospective, global, multi-center, non-randomized, observational trial. Subjects will be treated with the PulseSelect™ PFA System and followed through 36 months.

Conditions

Interventions

DEVICE

PulseSelect™ PFA system

Ablation using the PulseSelect™ PFA system

Sponsors & Collaborators

  • Medtronic Cardiac Ablation Solutions

    lead INDUSTRY

Principal Investigators

  • Khaldoun Tarakji, MD · Medtronic CAS Chief Medical Officer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-04
Primary Completion
2026-06-01
Completion
2029-06-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06578104 on ClinicalTrials.gov